TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
SDS Life Science AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 79,806 | 67,075 | 59,663 |
Financial expenses | 1,397 | 12 | 3 |
Earnings before taxes | -2,477 | 2,491 | 10,371 |
EBITDA | -1,087 | 2,525 | 10,374 |
Total assets | 30,177 | 32,258 | 24,031 |
Current assets | 26,431 | 32,049 | 23,909 |
Current liabilities | 13,325 | 13,823 | 22,733 |
Equity capital | 1,052 | 1,247 | 1,210 |
- share capital | 200 | 200 | 200 |
Employees (average) | 45 | 34 | 27 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 3.5% | 3.9% | 5.0% |
Turnover per employee | 1,773 | 1,973 | 2,210 |
Profit as a percentage of turnover | -3.1% | 3.7% | 17.4% |
Return on assets (ROA) | -3.6% | 7.8% | 43.2% |
Current ratio | 198.4% | 231.9% | 105.2% |
Return on equity (ROE) | -235.5% | 199.8% | 857.1% |
Change turnover | 12,731 | 7,412 | 20,387 |
Change turnover % | 19% | 12% | 52% |
Chg. No. of employees | 11 | 7 | 3 |
Chg. No. of employees % | 32% | 26% | 13% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.